PPIPT01969
Target Protein Information
| Protein_Name | Hyccin |
|---|---|
| Protein_Sequence | MFTSEKGVVEEWLSEFKTLPETSLPNYATNLKDKSSLVSSLYKVIQEPQSELLEPVCHQLFEFYRSGEEQLLQFTLQFLPELIWCYLAVSASRNVHSSGCIEALLLGVYNLEIVDKQGHTKVLSFTIPSLSKPSVYHEPSSIGSMALTESALSQHGLSKVVYSGPHPQREMLTAQNRFEVLTFLLLCYNAALTYMPSVSLQSLCQICSRICVCGYPRQHVRKYKGISSRIPVSSGFMVQMLTGIYFAFYNGEWDLAQKALDDIIYRAQLELYPEPLLVANAIKASLPHGPMKSNKEGTRCIQVEITPTSSRISRNAVTSMSIRGHRWKRHGNTELTGQEELMEISEVDEGFYSRAASSTSQSGLSNSSHNCSNKPSIGKNHRRSGGSKTGGKEKETTGESCKDHFARKQTQRAQSENLELLSLKRLTLTTSQSLPKPSSHGLAKTAATVFSKSFEQVSGVTVPHNPSSAVGCGAGTDANRFSACSLQEEKLIYVSERTELPMKHQSGQQRPPSISITLSTD |
| Organism_Source | Homo sapiens |
| Functional_Classification | Uncharacterized protein |
| Cellular_Localization | Nucleus |
| Gene_Names | HYCC1 |
| UniProt_ID | Q9BYI3 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | WX-021 |
|---|---|
| Peptide_Sequence | LRXIQRXL |
| Peptide_Length | 8 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O |
| Chemical_Modification | X3=(S)-2-(4'-pentenyl)alanine; X7=(S)-2-(4'-pentenyl)alanine |
| Cyclization_Method | Main chain-main chain cyclization; X3<->X7; other bonds |
| Linear/Cyclic | Linear |
| N-terminal_Modification | Acetyl |
| C-terminal_Modification | ?-Ala-?-Ala-NH2 |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 912.10 |
|---|---|
| Aliphatic_Index | 146.25000 |
| Aromaticity | 0.00000 |
| Average_Rotatable_Bonds | 4.00000 |
| Charge_at_pH_7 | 1.99798 |
| Isoelectric_point | 12.50011 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 12 |
| Number_of_Hydrogen_Bond_Donors | 16 |
| Topological_Polar_Surface_Area | 433.91000 |
| X_logP_energy | -4.01496 |
Interaction Information
| Affinity | IC50=764 nM |
|---|---|
| Affinity_Assay | GeneBLAzer? Wnt u-lactamase reporter assay |
| PDB_ID | None |
| Type | Antagonist |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | STABILIZED BCL9 PEPTIDES FOR TREATMENT OF ABERRANT WNT SIGNALING |
| Release_Year | 2021 |
| Patent_ID | US20210292385A1 |